Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Reglitazar is a PPARɑ agonist and PPARγ agonist. Reglitazar rapidly stimulates glucose disposal rates by enhancing insulin signal transduction in skeletal muscle. Reglitazar improves insulin resistance in genetic and non-genetic insulin-resistant models. Reglitazar reverses hypertriglyceridemia in Zucker fatty and ventromedial hypothalamus-lesioned obese rats.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Reglitazar is a PPARɑ agonist and PPARγ agonist. Reglitazar rapidly stimulates glucose disposal rates by enhancing insulin signal transduction in skeletal muscle. Reglitazar improves insulin resistance in genetic and non-genetic insulin-resistant models. Reglitazar reverses hypertriglyceridemia in Zucker fatty and ventromedial hypothalamus-lesioned obese rats. |
Synonyms | JTT-501, JTT501, PNU-182716, PNU182716, PNU-716 |
Molecular Weight | 392.4 |
Formula | C22H20N2O5 |
CAS No. | 170861-63-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Reglitazar 170861-63-9 JTT-501 JTT501 JTT 501 PNU716 PNU 716 PNU-182716 PNU182716 PNU 182716 PNU-716 inhibitor inhibit